人福医药：控股子公司药品屈螺酮炔雌醇片获药品注册证书

Core Viewpoint - The company, Renfu Pharmaceutical, has received approval from the National Medical Products Administration for the registration of a contraceptive drug, Drospirenone and Ethinyl Estradiol Tablets [1] Company Summary - Renfu Pharmaceutical's subsidiary, Jiulong Renfu, has been granted a drug registration certificate for Drospirenone and Ethinyl Estradiol Tablets, which are intended for female contraception [1]